UK company announcements filtered and explained for private investors.
Kingfisher PLC (KGF) · 2026-05-26
Kingfisher reported Q1 sales of £3.3bn, down (0.7)% on an underlying like-for-like basis. The group reiterated its full-year guidance for adjusted profit before tax of c.£565m-£625m and free cash flow of c.£450m-£510m.
Diaceutics PLC (DXRX) · 2026-05-26
Diaceutics reported a return to profitability for FY 2025 as revenue grew 24% to £38.4 million on a constant currency basis. Adjusted EBITDA rose 80% to £7.6 million while the order book reached a record £38.9 million, supporting management confidence for 2026.
Serco Group plc (SRP) · 2026-05-26
Serco retained its facilities management contract with Norfolk and Norwich University Hospital in a 10-year deal worth over £270m. The agreement immediately aligns soft and hard facilities services at the site through to January 2037.
Poolbeg Pharma (POLB) · 2026-05-26
Poolbeg Pharma received FDA feedback broadly aligned with its proposed development pathway for POLB 001. The company achieved alignment on the Phase 3 clinical trial primary endpoint, supporting ongoing partnering discussions.
Helix Exploration (HEX) · 2026-05-26
Helix Exploration has commenced re-entry operations at its Inez #1 well to bring the Souris River interval into production. The company is rigged up and addressing lodged equipment as it transitions from exploration to commercial helium production.
AstraZeneca PLC (AZN) · 2026-05-26
AstraZeneca's Enhertu received a positive EU regulatory opinion for treating adult patients with previously treated HER2-positive metastatic solid tumours. If approved, it would be the first HER2-directed antibody drug conjugate to receive a tumour agnostic indication in the region.
Cora Gold Limited (CORA) · 2026-05-26
Cora Gold commenced the Front-End Engineering Design (FEED) process at its Sanankoro Gold Project in Mali. The study, led by SENET, is due for completion in H2 2026 ahead of potential construction.
KEFI Gold and Copper plc (KEFI) · 2026-05-26
KEFI said Tulu Kapi milestones are tracking at or ahead of schedule, with commissioning targeted for late 2027. The company replaced US$15m of short-term funding with long-term capital and appointed Stifel for a planned LSE Main Market move.
Georgina Energy Plc (GEX) · 2026-05-26
Georgina Energy has commenced pre-drilling civil engineering site works for the Hussar prospect re-entry in Western Australia. Contractors are preparing the airstrip and access tracks ahead of technical site inspections scheduled for June 2026.
Panther Metals Plc (PALM) · 2026-05-26
Panther Metals Plc has commenced a discovery-focused diamond drilling programme at the Awkward Conduit Target in Ontario. The initial phase involves a single 400-metre hole targeting a potential magmatic feeder system host to nickel, copper, and platinum group metals.
CRISM Therapeutics Corporation (CRTX) · 2026-05-26
CRISM Therapeutics Corporation launched a retail offer to raise up to £100,000 at 10.0p per share. The raise supports Phase 2 trials for chemotherapy delivery and helps secure potential grant funding.
Anglesey Mining plc (AYM) · 2026-05-26
Anglesey Mining appointed Andrew Fulton as CEO and completed the initial phase of its drone-operated aero-geophysics programme. Preliminary results suggest potential mineralisation extensions at the Parys Mountain project. The company has reduced debt to approximately £100k following a capital restructuring.
Taseko Mines Limited (TKO) · 2026-05-26
Executive Terry Morris acquired 11,000 common shares at an average price of C$8.97 (approximately £4.82) per share. The transaction occurred on May 21, 2026.
CVS Group plc (CVSG) · 2026-05-26
Laura Hagan will succeed Deborah Kemp as Senior Independent Director and Employee Engagement Director on 1 July 2026. Helen Keays will become Chair of the Remuneration Committee on the same date following Deborah Kemp's retirement on 30 June 2026.
Cohort plc (CHRT) · 2026-05-26
Cohort plc announced that it will release its trading update for the full year on 27 May 2026. The notice is a routine administrative filing providing the reporting date for investors ahead of the scheduled results.
genedrive plc (GDR) · 2026-05-26
Chairman Dr. Ian Gilham will step down by June 2026, and NED Chris Yates will depart in the coming weeks. David Nugent joined the board today as a Non-Executive Director. The company is recruiting for a new Chairman and two additional directors.
Tatton Asset Management plc (TAM) · 2026-05-26
Tatton Asset Management will release its final results for the 12 months ended 31 March 2026 on 16 June 2026. An analyst briefing will be held on the release date followed by an investor presentation on 19 June 2026.
Surface Transforms plc (SCE) · 2026-05-26
Surface Transforms plc ordinary shares have been cancelled from trading on AIM effective 26 May 2026. The action was taken pursuant to AIM Rule 1.
PipeHawk plc (PIP) · 2026-05-26
PipeHawk confirmed the satisfaction of the National Security and Investment (NSI) Act condition for its disposal of Utsi Electronics Limited. The transaction remains subject to customary closing conditions and deliverables.
Gem Resources Plc (GEMR) · 2026-05-26
Gem Resources Plc denied market speculation suggesting it intends to cancel its London listing and become a private company. The Board confirmed that no such decision has been taken and there is no current intention to delist.